These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 16796706

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lack of dose-dependent effects of itraconazole on the pharmacokinetic interaction with fexofenadine.
    Uno T, Shimizu M, Sugawara K, Tateishi T.
    Drug Metab Dispos; 2006 Nov; 34(11):1875-9. PubMed ID: 16928786
    [Abstract] [Full Text] [Related]

  • 3. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism.
    Shon JH, Yoon YR, Hong WS, Nguyen PM, Lee SS, Choi YG, Cha IJ, Shin JG.
    Clin Pharmacol Ther; 2005 Aug; 78(2):191-201. PubMed ID: 16084853
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of fexofenadine enantiomers in healthy subjects.
    Miura M, Uno T, Tateishi T, Suzuki T.
    Chirality; 2007 Mar; 19(3):223-7. PubMed ID: 17230498
    [Abstract] [Full Text] [Related]

  • 5. Clinical pharmacokinetics of fexofenadine enantiomers.
    Miura M, Uno T.
    Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):69-74. PubMed ID: 19947891
    [Abstract] [Full Text] [Related]

  • 6. Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics.
    Yasui-Furukori N, Uno T, Sugawara K, Tateishi T.
    Clin Pharmacol Ther; 2005 Jan; 77(1):17-23. PubMed ID: 15637527
    [Abstract] [Full Text] [Related]

  • 7. Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein.
    Shimizu M, Uno T, Sugawara K, Tateishi T.
    Br J Clin Pharmacol; 2006 May; 61(5):538-44. PubMed ID: 16669847
    [Abstract] [Full Text] [Related]

  • 8. Time-dependent interaction between lopinavir/ritonavir and fexofenadine.
    van Heeswijk RP, Bourbeau M, Campbell P, Seguin I, Chauhan BM, Foster BC, Cameron DW.
    J Clin Pharmacol; 2006 Jul; 46(7):758-67. PubMed ID: 16809801
    [Abstract] [Full Text] [Related]

  • 9. Effect of St John's wort on the disposition of fexofenadine in the isolated perfused rat liver.
    Turkanovic J, Ngo SN, Milne RW.
    J Pharm Pharmacol; 2009 Aug; 61(8):1037-42. PubMed ID: 19703347
    [Abstract] [Full Text] [Related]

  • 10. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
    Tashiro M, Sakurada Y, Iwabuchi K, Mochizuki H, Kato M, Aoki M, Funaki Y, Itoh M, Iwata R, Wong DF, Yanai K.
    J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
    [Abstract] [Full Text] [Related]

  • 11. Effect of piperine, a major component of black pepper, on the intestinal absorption of fexofenadine and its implication on food-drug interaction.
    Jin MJ, Han HK.
    J Food Sci; 2010 Apr; 75(3):H93-6. PubMed ID: 20492299
    [Abstract] [Full Text] [Related]

  • 12. The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers.
    Tateishi T, Miura M, Suzuki T, Uno T.
    Br J Clin Pharmacol; 2008 May; 65(5):693-700. PubMed ID: 18294330
    [Abstract] [Full Text] [Related]

  • 13. Itraconazole greatly increases plasma concentrations and effects of felodipine.
    Jalava KM, Olkkola KT, Neuvonen PJ.
    Clin Pharmacol Ther; 1997 Apr; 61(4):410-5. PubMed ID: 9129558
    [Abstract] [Full Text] [Related]

  • 14. Relative contribution of absorptive and secretory transporters to the intestinal absorption of fexofenadine in rats.
    Ujie K, Oda M, Kobayashi M, Saitoh H.
    Int J Pharm; 2008 Sep 01; 361(1-2):7-11. PubMed ID: 18572335
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of first-pass cytochrome P4503A (CYP3A) and P-glycoprotein activities using alfentanil and fexofenadine in combination.
    Kharasch ED, Walker A, Hoffer C, Sheffels P.
    J Clin Pharmacol; 2005 Jan 01; 45(1):79-88. PubMed ID: 15601808
    [Abstract] [Full Text] [Related]

  • 16. Effects of the P-glycoprotein inducer carbamazepine on fexofenadine pharmacokinetics.
    Yamada S, Yasui-Furukori N, Akamine Y, Kaneko S, Uno T.
    Ther Drug Monit; 2009 Dec 01; 31(6):764-8. PubMed ID: 19855315
    [Abstract] [Full Text] [Related]

  • 17. Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides.
    Dresser GK, Kim RB, Bailey DG.
    Clin Pharmacol Ther; 2005 Mar 01; 77(3):170-7. PubMed ID: 15735611
    [Abstract] [Full Text] [Related]

  • 18. Effects of multiple-dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers.
    Akamine Y, Miura M, Yasui-Furukori N, Ieiri I, Uno T.
    J Clin Pharm Ther; 2015 Feb 01; 40(1):98-103. PubMed ID: 25263393
    [Abstract] [Full Text] [Related]

  • 19. Effect of itraconazole on pharmacokinetics of paroxetine: the role of gut transporters.
    Yasui-Furukori N, Saito M, Niioka T, Inoue Y, Sato Y, Kaneko S.
    Ther Drug Monit; 2007 Feb 01; 29(1):45-8. PubMed ID: 17304149
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy of wheal-and-flare suppression among various non-sedating antihistamines and the pharmacologic insights to their efficacy.
    Roongapinun S, Wajajamreon S, Fooanant S.
    J Med Assoc Thai; 2004 May 01; 87(5):551-6. PubMed ID: 15222528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.